The pandemic does not end until it ends everywhere
Em janeiro de 2021, o diretor-geral da Organização Mundial da Saúde, Tedros Adhanom Ghebreyesus, lançou um aviso que transcendia a urgência imediata da pandemia: a forma como o mundo distribuísse as vacinas revelaria o que a humanidade realmente valoriza quando confrontada com uma crise partilhada. Nações ricas corriam a assegurar doses para as suas populações, enquanto países mais pobres aguardavam, e Ghebreyesus nomeou esse padrão com clareza — nacionalismo vacinal — alertando que era não apenas injusto, mas contraproducente. Uma pandemia não termina em nenhum lugar enquanto não terminar em todo o lado, e a tentação de vencer sozinho garantia, na prática, que ninguém vencesse depressa.
- Com mais de 101 milhões de infetados e 2,19 milhões de mortos registados, a pressão sobre os governos para proteger primeiro os seus cidadãos era avassaladora — e perigosa.
- Nações ricas acumulavam doses enquanto países sem poder negocial aguardavam, aprofundando desigualdades que a pandemia já tinha exposto de forma brutal.
- Profissionais de saúde continuavam desprotegidos apesar de absorverem a maior exposição ao vírus, tornando a sua vacinação prioritária uma questão de sobrevivência do próprio sistema.
- O mecanismo Covax existia como resposta coletiva, mas dependia de uma escolha política que poucos governos estavam dispostos a fazer: partilhar excedentes antes de satisfazer a procura doméstica.
- Mesmo em países ricos como Portugal, onde a vacinação começara a 27 de dezembro, a distribuição revelava-se desigual e sujeita a pressões, sinalizando que a equidade era um desafio interno tanto quanto global.
- A pergunta que pairava sobre o discurso de Ghebreyesus era simples e sem resposta garantida: existia vontade política real para tratar a vacinação como um bem público global?
Numa tarde de janeiro de 2021, em Genebra, Tedros Adhanom Ghebreyesus dirigiu-se ao mundo com um aviso que misturava epidemiologia e ética: o modo como as vacinas fossem distribuídas determinaria não apenas quem sobreviveria nos meses seguintes, mas se a pandemia alguma vez terminaria verdadeiramente. As nações ricas já se moviam para garantir doses para as suas populações, e o diretor-geral da OMS nomeou esse impulso sem rodeios — nacionalismo vacinal — acrescentando que era, em última análise, autodestrutivo.
A lógica era implacável na sua simplicidade. Um vírus contido num lugar pode mutar e regressar de outro. Deixar metade do mundo desprotegida não era generosidade adiada; era uma estratégia que prolongava o risco para todos, incluindo os países que haviam acumulado mais doses. Ghebreyesus apelou a três compromissos concretos: priorizar os profissionais de saúde, vacinar os mais velhos e os clinicamente vulneráveis, e partilhar excedentes através do mecanismo Covax — o instrumento criado para garantir acesso a países sem capacidade de negociar os seus próprios contratos.
O contexto era de crise declarada. Mais de 101 milhões de infetados e 2,19 milhões de mortos pesavam sobre o mundo. Em Portugal, onde a vacinação começara a 27 de dezembro com trabalhadores hospitalares, quase 12 mil pessoas tinham morrido. A distribuição avançava para lares, bombeiros, forças de segurança e maiores de oitenta anos — mas já surgiam críticas: pessoas fora dos grupos prioritários recebiam doses, revelando que mesmo nas nações mais ricas a equidade era frágil.
O que Ghebreyesus descrevia era, no fundo, uma crise de ação coletiva. Cada governo tinha incentivos para vacinar primeiro os seus cidadãos, e cada governo enfrentava pressão doméstica para o fazer. Mas se todos agissem assim, o resultado seria uma pandemia prolongada, novas variantes e um caminho mais lento para o fim — para todos. O Covax existia precisamente para quebrar esse ciclo, mas dependia de uma escolha que a política tornava difícil: ver a vacinação como um bem global e não como um recurso nacional a monopolizar. Enquanto Ghebreyesus falava, esse teste estava apenas a começar.
Tedros Adhanom Ghebreyesus stood before the cameras in Geneva on a January afternoon in 2021, delivering a warning that would echo through the months ahead. The director-general of the World Health Organization had watched the pandemic expose the fault lines running through the global system—and now, he feared, the vaccine rollout threatened to carve those lines even deeper. The risk was real and immediate: wealthy nations were already moving to secure doses for their own populations, leaving poorer countries to wait. This, Ghebreyesus said plainly, was vaccine nationalism, and it was self-defeating.
The math was brutal in its simplicity. Vaccines were finite. The world had limited supply and infinite need. How those doses were distributed would determine not just who lived and who died in the coming months, but whether the pandemic would ever truly end. Ghebreyesus pressed the point: a virus contained in one place is a virus that can mutate and spread everywhere. The pandemic, he insisted, does not conclude until it concludes everywhere.
He called on governments to make three commitments. First, prioritize healthcare workers—the people on the front lines, absorbing the highest exposure, often with the least protection. Second, vaccinate the elderly and those at greatest medical risk. Third, share surplus doses through Covax, the global distribution mechanism designed to funnel vaccines to countries that could not negotiate their own supply deals. It was a plea for equity dressed in epidemiological logic. But the logic was sound: if you want the pandemic to end, you cannot leave half the world unprotected.
The numbers at that moment told the story of a world in crisis. More than 101 million confirmed infections had been recorded globally, with at least 2.19 million deaths. In Portugal alone, where vaccination had begun just weeks earlier on December 27th, nearly 12,000 people had died from the virus. The country's rollout had started with hospital workers, then moved to nursing home staff and residents. By the following week, firefighters, police, military personnel, and people over eighty would be eligible, along with younger people with serious underlying conditions. But already, criticism was mounting: people outside the priority groups had received doses, a sign that even in wealthy nations, the distribution was uneven and subject to pressure.
Ghebreyesus acknowledged the political temptation. Vaccine nationalism offered short-term wins—a government could tell its citizens that their elderly would be protected first, that their healthcare system would be shielded. But this thinking, he warned, was ultimately destructive. It assumed the pandemic could be won through hoarding, through national advantage, through the simple arithmetic of securing more than your neighbor. It could not. The virus did not respect borders. It did not care about GDP or military power. It moved through populations, mutated, and waited for the unvaccinated to provide it new hosts.
What Ghebreyesus was articulating, though he did not use these words, was a crisis of collective action. Every nation had an incentive to vaccinate its own people first. Every government faced domestic pressure to do so. But if every nation acted on that incentive, the result would be prolonged pandemic, new variants, and ultimately a slower path to the end for everyone, including the wealthy nations that had secured the most doses. The only way out was coordination, equity, and a willingness to see vaccination as a global public good rather than a national resource to be monopolized.
The question hanging over his remarks was whether that willingness existed. Covax had been designed precisely to answer this question—to create a mechanism that would ensure poor countries got access to vaccines. But Covax depended on wealthy nations actually sharing doses, on governments choosing the long-term logic of pandemic control over the short-term politics of national priority. As Ghebreyesus spoke, that test was just beginning. The answer would shape not just the trajectory of COVID-19, but the credibility of global health cooperation itself.
Citações Notáveis
Vaccine nationalism may achieve short-term political goals, but it is a self-defeating approach— Tedros Adhanom Ghebreyesus, WHO Director-General
Healthcare workers need vaccines now—they are frequently underprotected despite being overexposed to the virus— Tedros Adhanom Ghebreyesus
A Conversa do Hearth Outra perspectiva sobre a história
Why does Tedros keep saying the pandemic won't end until it ends everywhere? Isn't that just rhetoric?
No—it's epidemiology. A virus needs unvaccinated people to survive and mutate. If you leave half the world open, you're leaving the door open for new variants that could evade immunity in vaccinated populations. It's not morality; it's mechanics.
But governments have to answer to their own citizens first, don't they? Why shouldn't a country vaccinate its elderly before sending doses abroad?
They should vaccinate their elderly. But the choice isn't between vaccinating your elderly or vaccinating the world. It's between vaccinating your elderly and hoarding everything else, versus vaccinating your elderly and sharing the surplus. Tedros is asking for the second.
What's the actual risk if wealthy nations just keep the vaccines for themselves?
A prolonged pandemic. New variants emerging in unvaccinated populations. Economic disruption that continues for years instead of months. And the moral weight of knowing you could have prevented deaths but chose not to.
Covax sounds like it should work. Why would countries not participate?
Because in January 2021, there's scarcity. No one knows if there will be enough vaccines for everyone. Sharing feels like losing. Governments face domestic anger if they send doses abroad while their own elderly are still waiting. The incentive structure is broken.
So Tedros is essentially asking countries to act against their own short-term interests?
Yes. He's asking them to see that their long-term interest—ending the pandemic—requires it. Whether they listen is another question.